New placental patch shows promise for diabetic foot ulcers

NCT ID NCT06511596

Completed Disease control Sponsor: BioStem Technologies Source: ClinicalTrials.gov ↗

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study tested whether adding a special placental membrane (BR-AC) to standard wound care helps heal diabetic foot ulcers faster. 71 adults with diabetes and foot ulcers were randomly assigned to get either standard care alone or standard care plus BR-AC. The main goal was to see if more ulcers closed completely within 12 weeks. People who didn't heal with standard care could later receive BR-AC.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance: BR-AC (a placental membrane made from amnion, intermediate, and chorion layers)
What this could lead to: If it works, this could offer a new option to help heal stubborn diabetic foot ulcers faster and reduce the risk of complications.
What could go wrong: This is a small, completed trial with only 71 participants. Results may not apply to everyone, and the treatment may not work better than standard care alone.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for DIABETIC FOOT ULCER are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

Diabetic Foot

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

DIABETIC FOOT ULCER

Contacts and locations

Locations

Site 01

Vista, California, 92081, United States
Site 02

San Francisco, California, 94115, United States
Site 03

Fort Worth, Texas, 76104, United States
Site 04

Sylmar, California, 91342, United States
Site 05

McAllen, Texas, 78501, United States
Site 06

O'Fallon, Illinois, 62269, United States
Site 07

Torrance, California, 90502, United States
Site 08

North Chicago, Illinois, 60064, United States
Site 09

Frisco, Texas, 75034, United States
Site 10

Westwood, New Jersey, 07675, United States
Site 11

Miami, Florida, 33175, United States

More trials for these conditions

Other studies related to the condition(s) this trial covers.